You are here

Article Text

Article menu
Download PDFPDF
Editorial
Is there any place for oral anti-restenotic treatment in the era of drug eluting stents?
  1. A H Gershlick
  1. Correspondence to:
    Dr Anthony H Gershlick
    University of Leicester School of Medicine, Glenfield General Hospital, Leicester LE3 9QP, UK; agershlickaol.com

Abstract

Are drug eluting stents destined to become the standard of care for all patients undergoing percutaneous coronary intervention, or are alternative therapeutic approaches preferable under certain circumstances?

  • CABG, coronary artery bypass graft surgery
  • DES, drug eluting stents
  • MACE, major adverse cardiac events
  • PCI, percutaneous coronary intervention
  • TLR, target lesion revascularisation
  • TVR, target vessel revascularisation
  • drug eluting stents
  • percutaneous coronary intervention
  • rapamycin

https://doi.org/10.1136/hrt.2005.060954

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text